drugset / Trial / NCT06376981

Hyaluronic Acid in Shoulder Tendinopathy

NCT06376981

Phase 3 Recruiting 132 enrolled Centre Hospitalier Departemental Vendee
RandomizedParallel-groupDouble-blindTreatment

Summary

Multicentric, randomised study to compare the effectiveness on activity pain at 3 months of corticosteroid injection associated with hyaluronic acid with corticosteroids injection alone in patients with tendinopathy of the supraspinatus with clinical reevaluation at one, three and six months.

Timeline

Start
2024-09-19
Primary completion
2026-12-19
Completion
2030-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 2 ml

Indications